Bruce Goldman is a journalist based in California, focusing on local news and stories related to Stanford University. His articles cover a wide range of topics, including healthcare, medicine, science, and social issues. Bruce's work has been featured in publications such as Nextgov/FCW, Own Your Futurity, and Medical Xpress.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Bruce Goldman’s articles predominantly focus on scientific themes within the medical and healthcare sectors, particularly emphasizing data-driven content. Given this, he would likely be interested in pitches offering access to new research findings or breakthroughs in the medical field.
As his coverage focuses heavily on citing data and expert commentary, potential sources should ensure that they can provide factually accurate information. Pitches involving experts who have conducted extensive research or are involved in notable medical studies may resonate well with him.
Considering Bruce's local geographic focus around California’s Stanford area, relevant pitches could include insights from researchers at Stanford University or other esteemed institutions within California conducting cutting-edge medical research.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Erin Digitale, Katia Savchuk, Ruthann Richter, Bruce Goldman
Vision damage from a complication of premature birth can be halted if it’s caught soon enough — and a California Perinatal Quality Care (CPQCC) and Stanford Medicine-led study shows the state’s screening process is helping close racial gaps.
By: Hanae Armitage, Bruce Goldman, Erin Digitale, Hadley Leggett
Custom designing proteins — a breakthrough recognized by the latest Nobel Prize in chemistry — could yield treatments that stop the worst of COVID-19 before it begins.
By: Krista Conger, Margarita Gallardo, Mark Conley, Hadley Leggett, Bruce Goldman
Bryant Lin has taken his diagnosis of stage IV ‘never-smoker’ lung cancer, which disproportionately affects those of Asian descent, and turned it into a medical school course. He hopes the world takes notes along with the students and Stanford Medicine community.
By: Bruce Goldman, Nina Bai, Mandy Erickson, Kimberlee D'Ardenne
Stanford Medicine researchers on the hunt for an elusive cardiac fibrosis drug were surprised when a malaria drug with ancient origins emerged as their top candidate.
By: Bruce Goldman, Ruthann Richter, Nina Bai, Lindzi Wessel
Biodesign program aims to ensure all trainees have a better understanding of health equity and appreciate the ways in which new technologies can widen or narrow the gaps in access to care.
By: Daphne Sashin, Holly Maccormick, Mark Conley, Ruthann Richter, Bruce Goldman
When the new Stanford Hospital opened five years ago, a carefully designed third-floor resource center gave for those caring for loved ones an important safe haven.
Welcome to Stanford Medicine's Health Compass podcast, your go-to source for bringing the latest medical research to life through engaging and relatable stories that connect with your everyday health experiences. Join Maya Adam, MD, Director of Health Media Innovation and a Stanford Medicine faculty member, as she interviews leading experts on crucial health topics featured in Stanford Medicine
By: Bruce Goldman, Krista Conger, Sarah C. P. Williams, Mark Conley
Some researchers and clinicians are questioning the value of the body mass index, which estimates a person’s body composition. But do better alternatives exist?
Around 1.5 billion people globally experience some level of hearing loss -- that's nearly 20% of the world's population. Losing the ability to hear can be devastating, and navigating the potential treatments isn't always straight forward.
By: Bruce Goldman, Rachel Tompa, Sarah C. P. Williams, Christopher Vaughan, Jennifer Welsh
Giselle Salmasi’s collaboration with a colleague at the Mayo Clinic gives a patient with a recently identified blood clotting disease a new lease on life.
(833) 317-6278 
